Financials

News Ideas Technicals Forecast

SPRY fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of ARS Pharmaceuticals, Inc.

Total assets of SPRY for Q1 24 is 227.58 M USD, 2.40% less than the previous Q4 23. And total liabilities increased by 53.01% in Q1 24 to 3.71 M USD.

Q2 '22

Q3 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q2 '22

Q3 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—